批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1992/12/07 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/10/31 |
SUPPL-33(补充) |
Approval |
REMS - MODIFIED - D-N-A |
N/A
|
|
|
| 2023/12/15 |
SUPPL-31(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/03/04 |
SUPPL-29(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/10/07 |
SUPPL-28(补充) |
Approval |
Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2018/09/18 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/09/18 |
SUPPL-26(补充) |
Approval |
REMS - PROPOSAL - D-N-A |
N/A
|
|
|
| 2016/12/16 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert,Labeling-Package Insert |
STANDARD
|
|
|
| 2016/02/12 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2016/02/12 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2016/02/05 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/03/09 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/02/16 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2013/11/14 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2006/06/12 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/03/10 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2001/08/22 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1999/11/24 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1995/03/31 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 001 |
6589960 |
2020/11/09 |
|
Y |
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
| 6589960 |
2020/11/09 |
Y |
Y |
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
>>>活性成分:HYDROMORPHONE HYDROCHLORIDE; 剂型/给药途径:SOLUTION;ORAL; 规格:5MG/5ML; 治疗等效代码:AA<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 019891 |
001 |
NDA |
DILAUDID |
HYDROMORPHONE HYDROCHLORIDE |
SOLUTION;ORAL |
5MG/5ML |
Prescription |
Yes |
Yes |
AA |
1992/12/07
|
RHODES PHARMS |
| 074653 |
001 |
ANDA |
HYDROMORPHONE HYDROCHLORIDE |
HYDROMORPHONE HYDROCHLORIDE |
SOLUTION;ORAL |
5MG/5ML |
Prescription |
No |
No |
AA |
1998/07/29
|
HIKMA |
| 210176 |
001 |
ANDA |
HYDROMORPHONE HYDROCHLORIDE |
HYDROMORPHONE HYDROCHLORIDE |
SOLUTION;ORAL |
5MG/5ML |
Prescription |
No |
No |
AA |
2017/10/27
|
ASCENT PHARMS INC |